MINIMS CYCLOPENTOLATE HYDROCHLORIDE

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

इसे खरीदें

सक्रिय संघटक:

CYCLOPENTOLATE HYDROCHLORIDE

थमां उपलब्ध:

Bausch & Lomb UK Limited

ए.टी.सी कोड:

S01FA04

INN (इंटरनेशनल नाम):

CYCLOPENTOLATE HYDROCHLORIDE

डोज़:

1.0 %w/v

फार्मास्यूटिकल फॉर्म:

Eye Drops Solution

प्रिस्क्रिप्शन प्रकार:

Product subject to prescription which may be renewed (B)

चिकित्सीय क्षेत्र:

cyclopentolate

प्राधिकरण का दर्जा:

Marketed

प्राधिकरण की तारीख:

1979-04-01

सूचना पत्रक

                                MINIMS® CYCLOPENTOLATE HYDROCHLORIDE 1% W/V
EYE DROPS, SOLUTION
CYCLOPENTOLATE HYDROCHLORIDE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the
same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
IN THIS LEAFLET:
1. What Minims® Cyclopentolate Hydrochloride eye drops are and what
they are used for
2. What you need to know before you use your eye drops
3. How to use your eye drops
4. Possible side effects
5. How to store your eye drops
6. Contents of the pack and other information
1. WHAT MINIMS® CYCLOPENTOLATE HYDROCHLORIDE EYE DROPS ARE AND WHAT
THEY ARE USED FOR
Minims® Cyclopentolate Hydrochloride is a mydriatic and cycloplegic
drug. It is used to enlarge the pupil of the eye and to paralyse the
lens temporarily.
Your doctor or eye specialist may use it to examine your eye more
closely and/or prepare the eye for an operation.
These eye drops are also used to treat some types of inflammation of
the eye.
This medicine is not indicated for neonates (babies under 28 days old)
however, your doctor or eye specialist can use it if he/she decides
that it is necessary.
2. WHAT YOU NEED TO KNOW BEFORE YOU USE YOUR EYE DROPS
DO NOT USE MINIMS® CYCLOPENTOLATE HYDROCHLORIDE EYE DROPS:
•
if you are allergic to the active substance (cyclopentolate
hydrochloride) or any of the other ingredients of this medicine
(listed in
section 6).
•
if you have high pressure of liquid inside the eye (closed angle
glaucoma).
•
in babies under 28 days old (unless your doctor decides that it is
necessary).
•
if you are at risk of having an increased pressure in the eye,
especially if you are elderl
                                
                                पूरा दस्तावेज़ पढ़ें
                                
                            

उत्पाद विशेषताएं

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Cyclopentolate Hydrochloride 1.0% w/v.
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Eye drops, solution
Single-use, clear, colourless, sterile solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As a topical mydriatic and cycloplegic agent. Preoperative use in
ophthalmic surgery. Refraction and treatment of iritis
and iridocyclitis.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults (including the elderly)_
Instil dropwise into eye according to the recommended dosage.
For mydriasis: the recommended dosage in adults is one drop of the 1%
solution.
For refraction: 1 drop of solution, which may be repeated after five
minutes, is usually sufficient.
For iritis and iridocyclitis: 1-2 drops are instilled every six to
eight hours.
_Children and adolescents_
< 3 months:
Not recommended
3 months - 18 years:
To be used only at the discretion of the physician.
Method of administration
Ocular use.
Systemic absorption may be reduced by compressing the lacrimal sac at
the medial canthus for a minute during and
following the instillation of the drops. This blocks the passage of
the drops via the nasolacrimal duct to the wide
absorptive area of the nasal and pharyngeal mucosa. It is especially
advisable in children.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_0_
_/_
_0_
_4_
_/_

                                
                                पूरा दस्तावेज़ पढ़ें
                                
                            

इस उत्पाद से संबंधित अलर्ट देखें

दस्तावेज़ इतिहास देखें